SOLDES
Jusqu'à -70% sur une sélection d'articles*
Dermatomyositis, A Simple Guide To The Condition, Diagnosis, Treatment And Related Conditions
Par :Formats :
Disponible dans votre compte client Decitre ou Furet du Nord dès validation de votre commande. Le format ePub est :
- Compatible avec une lecture sur My Vivlio (smartphone, tablette, ordinateur)
- Compatible avec une lecture sur liseuses Vivlio
- Pour les liseuses autres que Vivlio, vous devez utiliser le logiciel Adobe Digital Edition. Non compatible avec la lecture sur les liseuses Kindle, Remarkable et Sony
, qui est-ce ?Notre partenaire de plateforme de lecture numérique où vous retrouverez l'ensemble de vos ebooks gratuitement
Pour en savoir plus sur nos ebooks, consultez notre aide en ligne ici
C'est si simple ! Lisez votre ebook avec l'app Vivlio sur votre tablette, mobile ou ordinateur :
- FormatePub
- ISBN978-1-370-83486-0
- EAN9781370834860
- Date de parution09/10/2016
- Protection num.pas de protection
- Infos supplémentairesepub
- ÉditeurEditeurs divers USA
Résumé
Dermatomyositis is a medical muscle disorder characterized by inflammation and a skin rash. It is a form of inflammatory myopathy (muscle disease). Dermatomyositis is connective tissue disease characterized by inflammation of muscles. Although dermatomyositis involves the skin and muscles, it may also involve other parts of the body such as joints, esophagus, lungs and heart. It is possible to divide the dermatomyositis into three basic subgroups according to cause:1.
Idiopathic dermatomyositis in adults.2. Childhood dermatomyositis or myositis with necrotizing vasculitis.3. Dermatomyositis linked with malignancy. It may be due to a viral infection involving the muscles or a disorder with the body's immune system. It can also sometimes occur in patients who have cancer of the lung, abdomen, or other body organ. Any person can develop dermatomyositis but it frequently happens in adults aged 40-60.
Dermatomyositis affects children aged 5-15 and as well as adults. There is:1. Sudden muscle weakness, stiffness, or soreness2. Purple-red skin rash3. Purple or violet colored upper eyelidsAutoantibodies are present:a. Antinuclear antibody (ANA) finding is positive in patients with dermatomyositis.b. Anti-Mi-2 antibodies are particular to dermatomyositisMuscle biopsy can be diagnostic. Early starting of medical treatment is important.
The disease is treated with anti-inflammatory medicines called corticosteroids and drugs that suppress the immune system. Intravenous immunoglobulin is proper treatment in patients with resistant dermatomyositis or aggressive diseaseOther treatments are antimalarial agents and immunomodulatory therapies1 in 5 people may recover and the symptoms disappear completely. Doctors have reported several such cases, especially in children.
Most cases are able to survive but may develop residual disability and muscle weakness. TABLE OF CONTENTIntroductionChapter 1 DermatomyositisChapter 2 CausesChapter 3 SymptomsChapter 4 DiagnosisChapter 5 TreatmentChapter 6 PrognosisChapter 7 PolymyositisChapter 8 Systemic Lupus ErythematosusEpilogue
Idiopathic dermatomyositis in adults.2. Childhood dermatomyositis or myositis with necrotizing vasculitis.3. Dermatomyositis linked with malignancy. It may be due to a viral infection involving the muscles or a disorder with the body's immune system. It can also sometimes occur in patients who have cancer of the lung, abdomen, or other body organ. Any person can develop dermatomyositis but it frequently happens in adults aged 40-60.
Dermatomyositis affects children aged 5-15 and as well as adults. There is:1. Sudden muscle weakness, stiffness, or soreness2. Purple-red skin rash3. Purple or violet colored upper eyelidsAutoantibodies are present:a. Antinuclear antibody (ANA) finding is positive in patients with dermatomyositis.b. Anti-Mi-2 antibodies are particular to dermatomyositisMuscle biopsy can be diagnostic. Early starting of medical treatment is important.
The disease is treated with anti-inflammatory medicines called corticosteroids and drugs that suppress the immune system. Intravenous immunoglobulin is proper treatment in patients with resistant dermatomyositis or aggressive diseaseOther treatments are antimalarial agents and immunomodulatory therapies1 in 5 people may recover and the symptoms disappear completely. Doctors have reported several such cases, especially in children.
Most cases are able to survive but may develop residual disability and muscle weakness. TABLE OF CONTENTIntroductionChapter 1 DermatomyositisChapter 2 CausesChapter 3 SymptomsChapter 4 DiagnosisChapter 5 TreatmentChapter 6 PrognosisChapter 7 PolymyositisChapter 8 Systemic Lupus ErythematosusEpilogue
A propos de Kenneth Kee
4,49 €
